Iain Stuart

CIK 1727756 · CHIEF SCIENTIFIC OFFICER · last filed 2026-04-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$72.9K

Companies

3

Total Filings

43

Lifetime Open-Market Net

-$27.1K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VYNE CHIEF SCIENTIFIC OFFICER 112,363 $0.65 $72.9K $0 28 2026-04-02
VYNE Therapeutics Inc. (MNLO) Delisted Chief Scientific Officer 291,018 $0 5 2020-07-02
Foamix Pharmaceuticals Ltd. (FOMX) Delisted Chief Scientific Officer 103,636 -$27.1K 9 2020-02-24

Recent Filings · Page 2 of 5

43 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-01-03 VYNE Mixed +62,343 -$358 EDGAR
2023-12-15 VYNE Grant (A) +62,500 $0 EDGAR
2023-10-04 VYNE Tax (F) −1,184 -$4.5K EDGAR
2023-07-05 VYNE Tax (F) −151 -$619 EDGAR
2023-04-04 VYNE Tax (F) −480 -$1.5K EDGAR
2023-01-04 VYNE Tax (F) −1,720 -$258 EDGAR
2022-10-04 VYNE Tax (F) −1,719 -$383 EDGAR
2022-07-05 VYNE Tax (F) −1,719 -$669 EDGAR
2022-04-04 VYNE Tax (F) −3,469 -$2.3K EDGAR
2022-03-18 VYNE Grant (A) +75,000 $0 EDGAR
Showing 1120 of 43
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.